Long Term Nebulised Gentamicin in Patients With Bronchiectasis
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The hypothesis of this randomized placebo controlled trial is that targeted nebulized
gentamicin to the airways will reduce bacterial burden and limit neutrophil airways
inflammation. If given long term this will improve symptoms, pulmonary physiology, exercise
capacity and health related quality of life with a reduction in exacerbation frequency and
health care utilization.